BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 18, 2008
View Archived Issues
Amyloid-beta protein dimers identified as cause of synapse impairment
Read More
Cara's peripherally active kappa opioid receptor agonist may be useful in treating visceral pain
Read More
New antidiabetic compounds described in recent patents
Read More
Effective antinociception without reward by novel endomorphin-1 analogue
Read More
VAP-1 ligands for diagnosing inflammatory disorders claimed in recent patent
Read More
Novel compounds with potential in the treatment of cancer disclosed
Read More
Mu opiod receptor agonist AS-006 effective in rat model of osteoarthritic pain
Read More
DiaMedica initiates enrollment in phase IIa clinical trial for DM-99 in type 2 diabetes
Read More
FDA approves Gen-Probe's supplemental regulatory application for Procleix Ultrio in HBV
Read More
SymBio and Eisai sign license agreement for bendamustine hydrochloride in Japan
Read More
Spectrum launches Fusilev injection and files amendment to NDA for tablet formulation
Read More
CV Therapeutics receives EMEA approval for Ranexa brand name
Read More
Abbott and AstraZeneca enter nonexclusive U.S. marketing agreement for Crestor
Read More
GTC and Ovation close agreement to develop and market ATryn in U.S
Read More
Nutra Pharma reports safety data from phase IIb/IIIa clinical study of RPI-78M in AMN
Read More
P-selectin inhibitor PSI-421 shows efficacy in models of vascular injury
Read More
Antisoma reports survival data from phase II study of ASA-404 in prostate cancer
Read More
FDA grants orphan drug designation to Santhera's omigapil in congenital muscular dystrophy
Read More
OrthoLogic completes dosing for phase Ib human clinical trial of AZX-100 in scarring
Read More
Seikagaku to initiate Japanese phase I clinical trial of CF-101 in rheumatoid arthritis
Read More
FDA approves Prestwick's Xenazine for chorea associated with Huntington's disease
Read More
Isis initiates phase I study of ISIS-353512 in healthy volunteers
Read More